91% of Healthcare Organizations Cannot Verify Which AI Systems Are Running

The control gap is measurable

Ninety-one percent of healthcare organizations surveyed cannot verify what AI is running in their environments, according to Clearwater Security & Compliance's 2026 Healthcare AI Security and Governance Benchmark covering 105 hospitals, health plans, and physician groups. Forty-two percent ranked sensitive data leakage through AI tools as their top internal concern, ahead of the 30.8% citing unsupervised use of unapproved AI.

The gap matters because it quantifies a widespread operational failure: governance programs exist, committees meet, policies are written, but most buyers cannot prove which systems are active or whether safeguards work. The competitive response is already visible. Three compliance-software financings closed in the past week—Comp at $34 million Series A, Readily at $11 million Series A, and Leela at $4.6 million seed—all positioning against the same problem: enterprises need continuous, technical proof of control, not attestations.

Governance budgets will shift toward discovery and monitoring

The Clearwater data indicates that healthcare governance spending must move from policy-writing and committee formation to asset discovery, endpoint monitoring, API controls, and continuous testing. Buyers evaluating AI-governance platforms should require vendors to demonstrate actual inventory coverage—how many models, APIs, copilots, and third-party tools the system identifies—and measurable control effectiveness, not policy templates.

A separate survey of 148 financial-services and healthcare leaders presented at SS&C's 2026 Deliver conference found that only 43% apply AI governance consistently across their entire business. Among organizations expecting AI agents to handle more than half of workflows, four in ten identified enterprise-wide governance as a top scaling priority. One in five cited AI-performance and ROI measurement as critical to success.

The SS&C data creates a budget tradeoff: enterprises scaling agents will need funding for controls and measurement alongside the agent licenses themselves. Procurement teams should treat governance coverage and agent observability as architecture requirements, not optional services added after deployment.

Compliance vendors are pivoting to continuous monitoring

Comp raised $34 million in Series A funding led by Roo Capital and Grand Ventures. The platform uses AI agents to draft security policies, collect audit evidence, monitor compliance controls continuously, and conduct AI-powered penetration testing of codebases and infrastructure. Comp competes with Drata, Vanta, Secureframe, Sprinto, Wiz, and established GRC suites, but positions its agent-based approach as reducing the labor required for SOC 2, ISO 27001, and related programs.

Buyers should test whether automated evidence collection integrates with their cloud providers, identity systems, ticketing platforms, and code repositories, and whether generated evidence is acceptable to auditors without extensive manual review. The competitive shift is toward continuous control monitoring rather than point-in-time questionnaire management.

Readily, a healthcare compliance platform, announced an $11 million Series A led by Define Ventures to expand regulatory-change tracking into enterprise oversight connecting obligations, execution, and emerging risks. Healthcare buyers evaluating Readily should distinguish regulatory-change tracking from full AI governance. The relevant questions are whether the platform can map obligations to specific AI systems, owners, controls, vendors, and audit evidence, and whether it supports HIPAA workflows and existing GRC integrations. The company has not disclosed customer count or deployment scale.

Leela emerged from stealth with a $4.6 million seed round led by Array Ventures and Female Founders Fund. The company offers an agentic AI platform for U.S.-regulated financial businesses with evidence and record preservation for compliance professionals. Financial institutions should demand immutable activity logs, explainable handoffs, retention controls, role-based access, and clear responsibility allocation when the agent makes or recommends a compliance action. At seed stage, Leela has not disclosed pricing, customers, or benchmarked accuracy.

What to require from AI-governance vendors

The week's data points to a clear procurement shift. Enterprises are struggling with AI inventory, consistent policy enforcement, agent oversight, evidence collection, and ROI measurement. Near-term requirements should include a continuously updated inventory of models, APIs, copilots, agents, and third-party AI tools; technical proof that data-loss prevention, access controls, human-review checkpoints, and logging operate as designed; audit-ready records of agent actions and human approvals; and integration with identity, cloud, ticketing, SIEM, DLP, and existing GRC systems.

Vendor pricing and service commitments should tie to monitored assets, users, models, or workflows—not vague "enterprise AI governance" packages. The 91% figure from Clearwater is the baseline: if a vendor cannot demonstrate inventory coverage across your environment, the governance program is decorative.